This is to inform the General Public that the following products are approved for withdrawal, suspension and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria. Please note that: 1. The Certificate of Registration of a product is said to be withdrawn when the use of the Certificate of Registration of that product is discontinued upon request of the Market Authorization Holder. 2. The Certificate of Registration of a product may be suspended when the conditions upon which the NAFDAC Registration license was issued are no longer met and the Agency is to make a determination. 3. The Certificate of Registration of a product is said to be cancelled when the NAFDAC Certificate of Registration license of that product is revoked by NAFDAC. |
| S/N | Product name | Dosage form | NAFDAC Number | Active Ingredient | Market Authorization Holder | Application Purpose |
|---|---|---|---|---|---|---|
| 1 | Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg Tablets | Tablets | C4-1180 | Abacavir sulfate and Lamivudine | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 2 | Amaryl M Tablets | Tablets | A4-2619 | Glimepiride + Metformin Hydrochloride | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 3 | Amaryl M SR Tablets | Tablets | A4-7296 | Glimepiride + Metformin Hydrochloride | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 4 | Aprovasc 150mg/5mg tablets | Tablets | B4-2687 | Amlodipine Besylate+Aprovasc | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 5 | Artemether/Lumefantrine 40mg/240mg Tablets | Tablets | B4-5745 | Artemether/Lumefantrine 40mg/240mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 6 | ASAQ(Artesunate amodiaquine Winthrop) 100mg/270mg Tablets | Tablets | A4-3357 | Artesunate Amodiaquine Winthrop 100mg/270mg | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 7 | ASAQ(Artesunate amodiaquine Winthrop) 25mg/67.5mg Tablets | Tablets | A4-3406 | Artesunate Amodiaquine Winthrop 25mg/67.5mg | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 8 | ASAQ(Artesunate amodiaquine Winthrop) 50mg/135mg Tablets | Tablets | A4-3405 | Artesunate Amodiaquine Winthrop 50mg/135mg | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 9 | Betopic Eye drop | Eye Drop | 04 2404 | Batexolol Hydrochloride | Novartis Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 10 | Coaprovel 300mg/25mg Tablets | Tablets | B4-2317 | Hydrochlorothiazize+Irbesartan | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 11 | Combination 3 Tablets | Tablet | A4-6459 | Estrogen, Progestin | Bayer East Africa Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 12 | Efavirenz 600mg Tablets | Tablets | A4-1318 | Efavirenz 600mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 13 | Elisca eye drop | Eye Drop | 04 2461 | Chloramphenicol Eye Drop | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 14 | Flagyl Suspension | Suspension | A4-3947 | Metronidaxole Benzoate | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 15 | Flagyl Tablet 400mg | Tablets | 04 5566 | Metronidaxole | Sanofi Aventis Nigeria ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 16 | Iliadin Adult 0.05% Metered Nose Spray | Spray | B4-9913 | Oxymetazoline HCl 0.05%M/V | Fensyl MHP Consulting Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 17 | Iliadin baby 0.01% nose drops | Spray | C4-0106 | Oxymetazoline HCl 0.01%M/V | Fensyl MHP Consulting Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 18 | Iliadin kids 0.025% nose drops | Spray | B4-9912 | Oxymetazoline HCl 0.025%M/V | Fensyl MHP Consulting Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 19 | Invanz 1g Injections | Injectables | 04 8118 | Ertapenem 1g | MSD Idea Pharmaceuticals Nigeria LTD | Withdrawn Voluntarily by Market Authorization Holder |
| 20 | Invega (Paliperidone) 3mg extended release tablets | Tablets | B4-8223 | Paliperidone | Janssen Pharmaceutical Companies | Withdrawn Voluntarily by Market Authorization Holder |
| 21 | Invega (Paliperidone) 6mg extended release tablets | Tablets | B4-8222 | Paliperidone | Janssen Pharmaceutical Companies | Withdrawn Voluntarily by Market Authorization Holder |
| 22 | Invega(Paliperidone) 9mg extended release tablets | Tablets | B4-8221 | Paliperidone | Janssen Pharmaceutical Companies | Withdrawn Voluntarily by Market Authorization Holder |
| 23 | Janumet 50mg/1000mg Tablets | Tablets | B4-1771 | Sitagliptin 50mg, Metformin Hydrochloride 1000mg | MSD Idea Pharmaceuticals Nigeria LTD | Withdrawn Voluntarily by Market Authorization Holder |
| 24 | Janumet 50mg/850mg Tablets | Tablets | B4-1637 | Sitagliptin 50mg, Metformin Hydrochloride 850mg | MSD Idea Pharmaceuticals Nigeria LTD | Withdrawn Voluntarily by Market Authorization Holder |
| 25 | Januvia 100mg Tablets | Tablets | B4-0023 | Sitagliptin 100mg | MSD Idea Pharmaceuticals Nigeria LTD | Withdrawn Voluntarily by Market Authorization Holder |
| 26 | Januvia 50mg Tablets | Tablets | B4-0335 | Sitagliptin 50mg | MSD Idea Pharmaceuticals Nigeria LTD | Withdrawn Voluntarily by Market Authorization Holder |
| 27 | Kombiglyze 2.5mg/1000mg tablets | Tablets | A4-9646 | Saxagliptin , Metformin Hcl | AstraZeneca Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 28 | Kombiglyze 5mg/1000mg tablets | Tablets | A4-9645 | Saxagliptin ,metformin Hcl | AstraZeneca Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 29 | Lamivudine/Nevirapine/Zidovudine Dispersible Tablets 150mg/200mg/300mg | Tablets | A4-2813 | Lamivudine/Nevirapine/Zidovudine Dispersible Tablets 150mg/200mg/300mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 30 | Lamivudine/Nevirapine/Zidovudine Dispersible Tablets 30mg/50mg/60mg | Tablets | A4-1319 | Lamivudine/Nevirapine/Zidovudine Dispersible Tablets 30mg/50mg/60mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 31 | Lexotan 3mg Tablets | Tablets | 04 8808 | Bromazepam | F. Hoffmann-La Roche Ltd. Basel, Switzerland. | Withdrawn Voluntarily by Market Authorization Holder |
| 32 | Mosegor Syrup | Syrup | 04 8106 | Pizotifen 0.05mg/ml | Novartis Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 33 | Nevirapine Tablets 200mg | Tablets | A4-1431 | Nevirapine 200mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 34 | Onglyza 2.5mg tablets | Tablets | A4-8864 | Saxagliptin | AstraZeneca Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 35 | Onglyza 5mg tablets | Tablets | A4-8863 | Saxagliptin | AstraZeneca Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 36 | Penicillin G Sodium Sandoz Powder for Solution for Injection | Injectables | B4-6367 | Benzylpenicillin 1000000IU | Novartis Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 37 | Salbutamol 100mcg Inhaler | Inhaler | B4-8493 | Salbutamol 100mcg | Novartis Nigeria Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 38 | Sporanox (Itraconazole) 100mg capsule | Capsule | 04 2404 | Itraconazole 100mg | Worldwide Healthcare Ventures Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 39 | Xyzal Oral Drops | Drops | B4-9691 | Levocetrizine Dihydrochloride | GlaxoSmithKline Pharmaceutical Nigeria Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 40 | Zidovudine 300mg Tablets | Tablets | A4-1314 | Zidovudine 300mg | Healthline Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 41 | Uptivite Man | Tablets | A7-101014L | Supplement | Gentlehills Limited | Cancelled by NAFDAC |
| 42 | Mist Alba Suspension | Suspension | A11-0871 | Magnesium Sulphate | Gentlehills Limited | Cancelled by NAFDAC |
| 43 | Gentle Hill Cough Syrup | Syrup | A11-0872 | Diphenhydramine HCl, Ammonium Chloride, Menthol ,Sodium Citrate | Gentlehills Limited | Cancelled by NAFDAC |
| 44 | Gentlehills Vitamin C Syrup | Syrup | A11-0936 | Ascobic Acid | Gentlehills Limited | Cancelled by NAFDAC |
| 45 | Mycobutin 150mg caps | Capsules | A4-4726 | Rifabutin 150mg | Pfizer Specialties Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 46 | Neo-Medrol Lotion | Lotion | 04-3778 | Methylprednisolone Acetate 2.5mg/neomycin sulphate 2.5mg | Pfizer Specialties Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 47 | Fortum Injection | Powder for injection | 04-2249 | Ceftazidime 1 gram (as Pentahydrate) | GlaxoSmithKline Pharmaceutical Nigeria Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 48 | Proximexa Injection | Powder for injection | A4-5555 | Cefuroxime Axetil 500mg | GlaxoSmithKline Pharmaceutical Nigeria Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 49 | Diclo-Neurobion tablets | Tablets | A4-1231 | Diclofenac sodium 50 mg, Vitamin B1 50 mg, Vitamin B6 50 mg, Vitamin B12 0.25 mg | Fensyl MHP Consulting Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 50 | Artemether 80mg/Lumefantrine 480mg tablets | Tablets | A4-101026 | Artemether 80mg/Lumefantrine 480mg | Lyn-Edge Pharmaceuticals Limited | Withdrawn Voluntarily by Market Authorization Holder |
| 51 | Fortum Injection 1g | Injectables | 04-2249 | Ceftazidime Pentahydrate | GlaxoSmithKline Pharmaceutical Nigeria Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 52 | Proximexa 500mg Tablets | Injectables | A4-5555 | Cefuroxime Axetil | GlaxoSmithKline Pharmaceutical Nigeria Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 53 | Mosegor Tablet | Tablet | 04 8106 | Pizotifen 0.05mg | Novartis | Withdrawn Voluntarily by Market Authorization Holder |
| 54 | Lexotan 3mg | Tablet | 04-8808 | Bromazepam | F.Hoffmann-La-Roche ltf | Withdrawn Voluntarily by Market Authorization Holder |
| 55 | Norditropin Nordiflex | Injectables | A6-100010 | Somatropin | Novo Nordisk Pharma | Withdrawn Voluntarily by Market Authorization Holder |
| 56 | Norditropin Nordiflex | Injectables | A6-100011 | Somatropin | Novo Nordisk Pharma | Withdrawn Voluntarily by Market Authorization Holder |
| 57 | Saxenda | Injectables | A6-100004 | Liraglutide 6.0 mg | Novo Nordisk Pharma | Withdrawn Voluntarily by Market Authorization Holder |
| 58 | Artemether Lumefantrine 80/480 Tablets | Tablet | A4-101026 | Artemether Lumefantrine 80/480 | Fredun Pharmaceuticals ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 59 | Cryomarex Rispens HVT | Vaccine | A6-0066 | Attenuated Marek's Disease Virus, Ripens Strain 1000 PFU | Fensyl MHP Consulting Ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 60 | Letrozole 2.5mg Tablet | Tablet | B4-7680 | Letrozole 2.5mg | Norvatis | Withdrawn Voluntarily by Market Authorization Holder |
| 61 | Zometa intravenous infusion | Infusion | A4-5636 | Zoledronic acid monohydrate | Norvatis | Withdrawn Voluntarily by Market Authorization Holder |
| 62 | Valsartan 80mg | Tablet | B4-7777 | Valsartan | Norvatis | Withdrawn Voluntarily by Market Authorization Holder |
| 63 | Valsartan 160mg | Tablet | B4-7682 | Valsartan | Norvatis | Withdrawn Voluntarily by Market Authorization Holder |
| 64 | Valsartan 50mg | Tablet | B4-7681 | Valsartan | Norvatis | Withdrawn Voluntarily by Market Authorization Holder |
| 65 | Prezista 75mg | Tablet | B4-7649 | Darunavir 600mg | Blooms Pharmaceutical ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 66 | Prezista 150mg | Tablet | B4-7650 | Darunavir 600mg | Blooms Pharmaceutical ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 67 | Prezista 600mg | Tablet | A4-7676 | Darunavir 600mg | Blooms Pharmaceutical ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 68 | Intelence 25mg | Tablet | A4-100493 | Etravirine | Blooms Pharmaceutical ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 69 | Intelence 100mg | Tablet | A4-8886 | Etravirine | Blooms Pharmaceutical ltd | Withdrawn Voluntarily by Market Authorization Holder |
| 70 | Abacavir Sulfate/Lamivudine Tablets for oral suspension120mg/60mg | Tablet | B4-8619 | Abacavir Sulfate/Lamivudine | Cipla | Withdrawn Voluntarily by Market Authorization Holder |
| 71 | Daktarin 2% 1x15g cream | Cream | 04-1589 | Miconazole nitrate | Johnson & Johnson | Withdrawn Voluntarily by Market Authorization Holder |
| 72 | coveram 10mg/10mg Tabelets | Tablet | A4-6817 | Perindopril 10mg/Amlodipine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 73 | Coveram 10mg/5mg Tablets | Tablet | A4-6818 | Perindopril 10mg/Amlodipine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 74 | Coveram 5mg/10mg Tablets | Tablet | A4-6816 | Perindopril 5mg/Amlodopine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 75 | Coveram 5mg/5mg Tablets | Tablet | A4-6819 | Perindopril 5mg/Amlodopine5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 76 | Coversyl 5mg Tablets | Tablet | A4-5001 | Perindopril 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 77 | Coversyl 10mg Tablets | Tablet | A4-5030 | Perindopril 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 78 | Coversyl plus 10mg/2.5mg Tablets | Tablet | B4-4158 | Perindopril 10 mg/ Indapamide2.5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 79 | Coversyl Plus 5mg/1.25mg Tablets | Tablet | B4-4159 | Perindopril 5 mg/ Indapamide1.25mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 80 | Natrilix SR 1.5mg Tablets | Tablet | 04-4159 | Indapimide SR 1.5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 81 | Vastarel MR 60mg | Tablet | B4-1945 | Trimetazidine dihydrochloride MR 35mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 82 | Diamicron MR 30mg Tablets | Tablet | B4-9083 | Gliclazide MR 30mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 83 | Diamicron MR 60mg | Tablet | A4-7426 | Gliclazide MR 60mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 84 | Daflon 1000mg | Tablet | A7-4942L | Micronized Purified Flavonoid Fraction | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 85 | Daflon 500mg | Tablet | 04-6857 | Micronized Purified Flavonoid Fraction | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 86 | Triveram 10mg/5mg/5mg | Tablet | C4-1735 | Atorvastatin 10mg/Perindopril 5mg/ Amlodipine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 87 | Triveram 20mg/5mg/5mg | Tablet | C4-1736 | Atorvastatin 20mg/Perindopril 5mg/ Amlodipine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 88 | Triveram 20mg/10mg/5mg | Tablet | C4-1737 | Atorvastatin 20mg/Perindopril 10mg/ Amlodipine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 89 | Triveram 20mg/10mg/10mg | Tablet | C4-1738 | Atorvastatin 20mg/Perindopril 10mg/ Amlodipine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 90 | Triveram 40mg/10mg/10mg | Tablet | C4-1739 | Atorvastatin 40mg/Perindopril 10mg/ Amlodipine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 91 | Viacoram 3.5mg/2.5mg | Tablet | C4-0375 | Perindopril 3.5mg/Amlodopine 2.5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 92 | Viacoram 7mg/5mg | Tablet | C4-0376 | Perindopril 7mg/Amlodopine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 93 | Natrixam 1.5mg/5mg | Tablet | B4-4153 | Indapimide 1.5mg/Amlodipine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 94 | Natrixam 1.5mg/10mg | Tablet | B4-4152 | Indapimide 1.5mg/Amlodipine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 95 | Coveram Plus 5mg/1.25mg/5mg | Tablet | B4-6499 | Perindopril 5mg/ Indapamide 1.25mg/Amlodopine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 96 | Coveram Plus 5mg/1.25mg/10mg | Tablet | B4-6500 | Perindopril 5mg/ Indapamide 1.25mg/Amlodopine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 97 | Coveram Plus 10mg/1.25mg/5mg | Tablet | B4-6497 | Perindopril 10mg/ Indapamide 1.25mg/Amlodopine 5mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 98 | Coveram Plus 10mg/1.25mg/10mg | Tablet | B4-6498 | Perindopril 10mg/ Indapamide 1.25mg/Amlodopine 10mg | Servier Pharmaceuticals Development ltd | Withdrawn Voluntarily by Market Authorization Holder from November 2025 |
| 101 | Mektovi 15mg Tablets | Tablets | A4-100332 | Binimitinib 15mg | Pfizer Specialties Limited | Withdrawn Voluntarily by Market Authorization Holder |
Was this helpful?
Thanks for your feedback!
